Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer

BACKGROUND: Oxaliplatin resistance is a major challenge for treatment of advanced colorectal cancer (CRC). Both acquisition of epithelial-mesenchymal transition (EMT) and suppressed drug accumulation in cancer cells contributes to development of oxaliplatin resistance. Aberrant expression of small n...

詳細記述

保存先:
書誌詳細
出版年:Mol Cancer
主要な著者: Liu, Tong, Zhang, Xin, Du, Lutao, Wang, Yunshan, Liu, Xiaoming, Tian, Hui, Wang, Lili, Li, Peilong, Zhao, Yinghui, Duan, Weili, Xie, Yujiao, Sun, Zhaowei, Wang, Chuanxin
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6423768/
https://ncbi.nlm.nih.gov/pubmed/30890168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-019-0981-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料